304 related articles for article (PubMed ID: 29984654)
1. Progressive Spatial Memory Impairment, Brain Amyloid Deposition and Changes in Serum Amyloid Levels as a Function of Age in APPswe/PS1dE9 Mice.
Fu L; Sun Y; Guo Y; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
Curr Alzheimer Res; 2018; 15(11):1053-1061. PubMed ID: 29984654
[TBL] [Abstract][Full Text] [Related]
2. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
[TBL] [Abstract][Full Text] [Related]
3. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
4. Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
O'Leary TP; Brown RE
Behav Brain Res; 2009 Jul; 201(1):120-7. PubMed ID: 19428625
[TBL] [Abstract][Full Text] [Related]
5. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
[TBL] [Abstract][Full Text] [Related]
6. Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain.
Yue X; Zhou Y; Qiao M; Zhao X; Huang X; Zhao T; Cheng X; Fan M; Zhao Y; Chen R; Zhu L
Alzheimers Res Ther; 2021 Nov; 13(1):194. PubMed ID: 34844651
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies of glial fibrillary acidic protein and brain-derived neurotrophic factor expression in two transgenic mouse models of Alzheimer's disease.
Edwards SR; Khan N; Coulson EJ; Smith MT
Clin Exp Pharmacol Physiol; 2020 Oct; 47(10):1740-1750. PubMed ID: 32542833
[TBL] [Abstract][Full Text] [Related]
8. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease.
Xiong H; Callaghan D; Wodzinska J; Xu J; Premyslova M; Liu QY; Connelly J; Zhang W
Neurosci Bull; 2011 Aug; 27(4):221-32. PubMed ID: 21788993
[TBL] [Abstract][Full Text] [Related]
10. Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease.
Ruan L; Kang Z; Pei G; Le Y
Curr Alzheimer Res; 2009 Dec; 6(6):531-40. PubMed ID: 19747158
[TBL] [Abstract][Full Text] [Related]
11. Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: involvement of oxidative stress and cholinergic dysfunction.
Zhang W; Bai M; Xi Y; Hao J; Liu L; Mao N; Su C; Miao J; Li Z
Free Radic Biol Med; 2012 Apr; 52(8):1443-52. PubMed ID: 22342520
[TBL] [Abstract][Full Text] [Related]
12. p75NTR regulates Abeta deposition by increasing Abeta production but inhibiting Abeta aggregation with its extracellular domain.
Wang YJ; Wang X; Lu JJ; Li QX; Gao CY; Liu XH; Sun Y; Yang M; Lim Y; Evin G; Zhong JH; Masters C; Zhou XF
J Neurosci; 2011 Feb; 31(6):2292-304. PubMed ID: 21307265
[TBL] [Abstract][Full Text] [Related]
13. [APPswe/PS1dE9/Blg Transgenic Mouse Line for Modeling Cerebral Amyloid Angiopathy Associated with Alzheimer's Disease].
Lysikova EA; Kuzubova EV; Radchenko AI; Patrakhanov EA; Chaprov KD; Korokin MV; Deykin AV; Gudyrev OS; Pokrovskii MV
Mol Biol (Mosk); 2023; 57(1):85-94. PubMed ID: 36976741
[TBL] [Abstract][Full Text] [Related]
14. Multiple inflammatory pathways are involved in the development and progression of cognitive deficits in APPswe/PS1dE9 mice.
Zhang W; Bai M; Xi Y; Hao J; Zhang Z; Su C; Lei G; Miao J; Li Z
Neurobiol Aging; 2012 Nov; 33(11):2661-77. PubMed ID: 22277264
[TBL] [Abstract][Full Text] [Related]
15. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice.
Wang J; Tanila H; Puoliväli J; Kadish I; van Groen T
Neurobiol Dis; 2003 Dec; 14(3):318-27. PubMed ID: 14678749
[TBL] [Abstract][Full Text] [Related]
17. Interplay of curcumin and its liver metabolism on the level of Aβ in the brain of APP
Mei X; Zhu L; Zhou Q; Li X; Chen Z
Pharmacol Rep; 2020 Dec; 72(6):1604-1613. PubMed ID: 32468514
[TBL] [Abstract][Full Text] [Related]
18. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
[TBL] [Abstract][Full Text] [Related]
19. A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease.
Bonardi C; de Pulford F; Jennings D; Pardon MC
Behav Brain Res; 2011 Sep; 222(1):89-97. PubMed ID: 21440575
[TBL] [Abstract][Full Text] [Related]
20. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
Garcia-Alloza M; Robbins EM; Zhang-Nunes SX; Purcell SM; Betensky RA; Raju S; Prada C; Greenberg SM; Bacskai BJ; Frosch MP
Neurobiol Dis; 2006 Dec; 24(3):516-24. PubMed ID: 17029828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
